News

James Hardie Industries (ASX:JHX) expects to achieve FY25 guidance despite economic headwinds

James Hardie Industries PLC (ASX:JHX) manufactures fiber cement and fiber gypsum building products which are utilised in commercial and residential construction. The company is committed to integrating sustainable practices into its operations, driving community impact and enhancing product resilience, as demonstrated through its sustainability …

Team Kalkine | 13 November 2024

Lycopodium (ASX:LYL) expects to benefit from energy sector’s transition to zero-carbon sources

Australia-basedLycopodium Limited (ASX:LYL)offers integrated solutions in construction, asset management and engineering. The company manages multidisciplinary, complex projects by offering advisory services and feasibility studies across the industrial processes, rail infrastructure and resources sectors.

Team Kalkine | 11 November 2024

Ramsay Health Care (ASX:RHC) expects NPAT to increase in FY25, but margin recovery may get affected

Ramsay Health Care Limited (ASX:RHC)operates a network of hospitals, clinics, imaging centres, day care surgery facilities and pharmacies across Australia, the UK and multiple other countries. The healthcare services provider achieved a 9.4% YoY increase in segment revenue and other income in the financial …

Team Kalkine | 06 November 2024

Vicinity Centres (ASX:VCX) expects FFO of 14.5-14.8 cents, and AFFO of 12.3-12.6 cents per share in FY25

Vicinity Centres (ASX:VCX)is a retail REIT company in Australia with retail assets under management. The company offers variety of retail, residential, and office spaces. In the financial year 2024 (FY24), the company witnessed an 117.6% YoY increase in net income to AUD 549 million …

Team Kalkine | 05 November 2024

Autosports Group’s (ASX: ASG) FY25 revenue likely to get a boost following Stillwell Motor acquisition

Autosports Group Limited (ASX: ASG)is an ASX-listed company engaged in the sale of used and new motor vehicles and provides a range of high-quality automotive options. The company also provides finance and insurance solutions and excels in aftermarket services, including collision repair, spare parts …

Team Kalkine | 04 November 2024

KKR Credit Income Fund (ASX: KKC) Delivers Total Return Exceeding 10% Over the Past Year

Private credit funds, like private equity funds, raise capital from investors, but instead of acquiring equity, they focus on providing loans. While most private credit funds operate without leverage, a smaller segment may utilise borrowing or derivatives to boost their returns.

Team Kalkine | 30 October 2024

Cogstate (ASX:CGS)  eyes revenue and profit growth in FY25 with increased contract value

Cogstate Limited(ASX:CGS) is an ASX-listed neuroscience technology company engaged in optimising cognitive assessments to aid the development of new therapeutics and delivering earlier brain health insights in clinical care.

Team Kalkine | 30 October 2024

OFX Group’s (ASX:OFX) H1FY25 earnings likely to be miss guidance. Here’s what to expect in H2

OFX Group Limited (ASX:OFX) is a Sydney-based cross-border payments company, offering foreign exchange and money transfers services across 50 currencies. The company focuses on corporate, enterprise and consumer clients in nine countries. The B2B segment of OFX is performing well recently, as it observed …

Team Kalkine | 29 October 2024

Flight Centre (ASX:FLT) uncertain about FY25 trading conditions, lines-up investments for long-term growth

Flight Centre (ASX:FLT) is one of the largest travel retailers and corporate travel managers in Australia, operating four divisions in four regions globally. In the financial year 2024 (FY24), the company generated record AUD 421 million in operating cash inflow and invested over AUD …

Team Kalkine | 28 October 2024

Key factors likely to drive Monash IVF Group’s (ASX:MVF) revenue and NPAT growth in FY25

Monash IVF Group Limited (ASX:MVF) provides fertility and reproductive services in Australia. The company provides multiple specialised services including gynaecological ultrasound, diagnostic obstetric and fertility treatments. The company focuses on expanding its presence in South-East Asian market.

Team Kalkine | 23 October 2024